Rapamycin inhibits cardiac hypertrophy by promoting autophagy via the MEK/ERK/Beclin-1 pathway
Rapamycin, also known as sirolimus, is an antifungal agent and immunosuppressant drug used to prevent organ rejection in transplantation. However, little is known about the role of rapamycin in cardiac hypertrophy and the signaling pathways involved. Here, the effect of rapamycin was examined using...
Main Authors: | Changqian eWang, Gu eJun, Wei eHu, Zhi-ping eSong, Yue-guang eChen, Da-dong eZhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-03-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphys.2016.00104/full |
Similar Items
-
The MEK/ERK Module Is Reprogrammed in Remodeling Adult Cardiomyocytes
by: Kubin Thomas, et al.
Published: (2020-09-01) -
Influence of RKIP Protein Complexes Concentrations on the Quasi-Stationary Behaviour of the MEK/ERK Signal Transduction Pathway
by: Petrov V., et al.
Published: (2007-12-01) -
Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting
by: Thomas eKnight, et al.
Published: (2014-06-01) -
Rigosertib inhibits MEK1–ERK pathway and alleviates lipopolysaccharide‐induced sepsis
by: Yin Wang, et al.
Published: (2021-09-01) -
Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway
by: Jun Wang, et al.
Published: (2020-10-01)